Stock 4557 MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Medical & Biological Laboratories Co., Ltd.

Equities

4557

JP3131450003

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers
CI
JSR Corporation acquired remaining 7.27% stake in Medical & Biological Laboratories Co., Ltd. for ¥1.7 billion.
CI
JSR Corporation completed the acquisition of an additional 41.91% stake in Medical & Biological Laboratories Co., Ltd. for ¥9.5 billion.
CI
JSR Corporation made an offer to acquire the remaining 49.2% stake in Medical & Biological Laboratories Co., Ltd. for ¥11.2 billion.
CI
Medical & Biological Laboratories Co., Ltd. Starts the Sale of A Test Kit (For Research Use Only) for Measuring SARS-CoV-2 Neutralizing Antibodies
CI
Medical & Biological Laboratories Co., Ltd. Announces “MEBRIGHTTM SARS-CoV-2 Kit” Was Approved with Marketing Authorization in Japan for the Detection of Novel Coronavirus “SARS-CoV-2”
CI
Medical and Biological Laboratories Co., Ltd. Concludes License Agreement with China National Biotec Group Co., Ltd
CI
Medical & Biological Laboratories Co., Ltd. Launches New ELISA-Based Companion Diagnostic Kit for Spinal Muscular Atrophy
CI
Pmt Corporation Co. Ltd. cancelled the acquisition of Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others.
CI
MEDICAL & BIOLOGICAL LABORATORIES Co., Ltd. Enters into Collaboration Agreement with the p53 Laboratory
CI
Pmt Corporation Co. Ltd. agreed to acquire Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others for ¥0.07 million.
CI
MBL International Corporation announced that it has received funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.
CI
MBL International Corporation announced that it expects to receive funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.
CI
Chiome Bioscience Inc. acquired remaining 47.1% stake in LivTech Inc. from Medical & Biological Laboratories Co., Ltd., KSP Inc., Kouji Nakamura, Hiroyuki Yanai and 3 other individuals.
CI
JSR Corporation completed the acquisition of 13.88% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.2 billion.
CI
JSR Corporation offered a take overbid to acquire 17.9% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.8 billion.
CI
Medical & Biological Laboratories, Co., Ltd. Opens MBL Europe Office in Diegem, Belgium
CI
Medical & Biological Laboratories Co., Ltd. cancelled the acquisition of histopathology examination businesses of Histo Science Laboratory Co., Ltd.
CI
Medical & Biological Laboratories Co., Ltd. cancelled the acquisition of remaining 91.3% stake in ACTGen, Inc. from Toshieki Kajikawa and other shareholders.
CI
Closed Merger/Acquisition Transaction – Target: LivTech Inc.; Buyer(s): Chiome Bioscience Inc.; Seller(s): JAFCO Incubation No. 2 Venture Capital Investment Limited Partnership, KSP Inc., MBL Venture Capital Co., Ltd., Medical & Biological Laboratories Co., Ltd., ReqMed Venture Capital, Yokohama Capital Co. Ltd.; Transaction Size: ¥87.75 mm
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4557 Stock
  4. News Medical & Biological Laboratories Co., Ltd.